| Print
AnaptysBio (ANAB)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) anda Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Address
10421 Pacific Center Court
Suite 200
San Diego
CA
USA
92121
Telephone
+1 858 3626295
Forecast key dates
| Name | Key Date |
|---|---|
| AnaptysBio Inc Third Quarter Earnings Results for 2026 | 2026-11-04T00:00:00 |
| AnaptysBio Inc Second Quarter Earnings Results for 2026 | 2026-08-06T00:00:00 |
| AnaptysBio Inc Annual General Meeting for 2026 | 2026-06-17T08:00:00 |
| AnaptysBio Inc First Quarter Earnings Results for 2026 | 2026-05-05T00:00:00 |
| AnaptysBio Inc Annual Report for 2025 | 2026-02-27T00:00:00 |
| AnaptysBio Inc Fourth Quarter Earnings Results for 2025 | 2026-02-27T00:00:00 |
| Evercore 8th Annual Healthcare Conference | 2025-12-03T07:55:00 |
| Piper Sandler 37th Annual Healthcare Conference | 2025-12-02T13:30:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.